Launched in 2020, the ORCHESTRA project was funded by the European Commission's Horizon 2020 programme with a grant of 30 million euros and has achieved concrete results in the fight against "Long Covid", the term that has been given to the condition to refer to the long-term consequences produced after having contracted the virus
A comprehensive analysis involving over 7,000 patients with mild to severe cases of Covid-19 from 50 European centers allowed ORCHESTRA to map, with precision, the link between virus variants and specific clinical conditions. Scientists identified four distinct clinical subtypes of Long Covid and were able to define the characteristics of patients at risk. The project also demonstrated the effectiveness of vaccines and monoclonal antibodies in reducing the risk of Long Covid by over 80% while monitoring the risk of resistance to these therapies, particularly in fragile patients with haematological neoplastic diseases.
The strong collaboration also led to the creation of The ORCHESTRA Data Portal, a data portal open to the international scientific community that brings together all the results and knowledge built from the contribution of all the centers involved in the project.
"ORCHESTRA does not limit itself to providing answers to the challenges of Covid," underlines Evelina Tacconelli, Director of the Infectious Disease Division of the University of Verona and coordinator of the project, "but looks to the future, helping us to prepare for the pandemics of tomorrow. The ORCHESTRA Data portal represents a precious legacy for the global scientific community, a treasure trove of information that will contribute to the fight against infectious with pandemic potential".
Over 100 scientific publications and numerous educational videos are testament to the impact of the project among both the scientific community and the public alike. ORCHESTRA has thus succeeded in demonstrating how scientific research can keep the public well-informed and provide a concrete and timely contribution during a health emergency, supporting doctors in their daily work and offering solutions for the future.
The Partner Meeting was also reason to celebrate achievements: The Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital was awarded the Publication Powerhouse Award (for Work Package 3, Leader: INSERM, Co-Leader: LMU) and theImpactFactor Champion Award (to LMU - HGMU) for the article"Seroepidemiology and model-based prediction of SARS-CoV-2 in Ethiopia: longitudinal cohort study among front-line hospital workers and communities" in Lancet Global Health. Many congrats to the team!
